Melissa B. Epperly - 20 Jan 2026 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Melissa Epperly
Issuer symbol
ROIV
Transactions as of
20 Jan 2026
Net transactions value
-$1,241
Form type
4
Filing time
22 Jan 2026, 21:00:29 UTC
Previous filing
22 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Epperly Melissa B, Director C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM By: /s/ Jo Chen, as Attorney-in-Fact for Melissa Epperly 22 Jan 2026 0001807359

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +815 +1.4% $0.000000 57,719 20 Jan 2026 Direct F1
transaction ROIV Common Shares Tax liability $1,241 -54 -0.09% $22.98 57,665 20 Jan 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.
F2 Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.